MAVIRET

AbbVie Secures EU Approval for MAVIRET in Acute Hepatitis C

NORTH CHICAGO, Ill., June 23, 2026 AbbVie announced that the European Commission has approved MAVIRET® (glecaprevir/pibrentasvir) for the treatment...

By cGxPwire Editor
June 24, 2026

.Clinical

AbbVie Reports Strong Phase 3 Results for MAVIRET in Acute HCV

North Chicago, Illinois, USA – May 22, 2026 AbbVie announced that the European Medicines Agency’s Committee for Medicinal Products...

By cGxPwire Editor
May 25, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

MAVIRET

AbbVie Secures EU Approval for MAVIRET in Acute Hepatitis C

AbbVie Reports Strong Phase 3 Results for MAVIRET in Acute HCV